STAAR Surgical Files 8-K on Financials

TL;DR

STAAR Surgical filed an 8-K on April 4th detailing financial results. Keep an eye on their performance.

AI Summary

STAAR Surgical Company filed an 8-K on April 4, 2024, reporting on its financial condition and results of operations. The filing includes financial statements and exhibits related to the period ending April 4, 2024. No specific financial figures or significant events were detailed in the provided excerpt.

Why It Matters

This filing provides an update on STAAR Surgical's financial performance and condition, which is crucial for investors to assess the company's health and future prospects.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.

Key Players & Entities

• STAAR Surgical Co (company) — Registrant
• Delaware (jurisdiction) — State of Incorporation
• April 4, 2024 (date) — Date of earliest event reported

FAQ

Filing Documents

• staa-20240404.htm (8-K) — 43KB
• staa-ex99_1.htm (EX-99.1) — 16KB
• img177331332_0.jpg (GRAPHIC) — 11KB
• 0000950170-24-041613.txt ( ) — 193KB
• staa-20240404.xsd (EX-101.SCH) — 29KB
• staa-20240404_htm.xml (XML) — 4KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On April 4, 2024, STAAR Surgical Company (the "Company") published a press release reporting preliminary net sales for the first quarter ended March 29, 2024, a copy of which is furnished as Exhibit 99.1 to this Current Report and is incorporated herein by this reference. The financial information is preliminary and subject to adjustment in the final financial statements to be filed with the Company's Quarterly Report on Form 10-Q for the three months ended March 29, 2024. The Company expects to report complete first quarter financial results and discuss its fiscal 2024 outlook during its quarterly earnings call on or about May 8, 2024. The information furnished herewith pursuant to Item 2.02 of this Current Report, including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in Item 2.02 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing .

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press release of the Company dated April 4, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STAAR Surgical Company April 4, 2024 By: /s/ Tom Frinzi Thomas Frinzi President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR